Bibliographic citations
Barboza, M., (2024). Caracterización de la resistencia bacteriana en infección urinaria de pacientes diabéticos en un hospital de Lima, 2023 [Universidad Privada Norbert Wiener]. https://hdl.handle.net/20.500.13053/12552
Barboza, M., Caracterización de la resistencia bacteriana en infección urinaria de pacientes diabéticos en un hospital de Lima, 2023 []. PE: Universidad Privada Norbert Wiener; 2024. https://hdl.handle.net/20.500.13053/12552
@misc{renati/1668415,
title = "Caracterización de la resistencia bacteriana en infección urinaria de pacientes diabéticos en un hospital de Lima, 2023",
author = "Barboza Zambrano, Milagros Antonet",
publisher = "Universidad Privada Norbert Wiener",
year = "2024"
}
The objective of this study was to characterize bacterial resistance in urinary tract infections among diabetic patients treated at a hospital in Lima during 2023. The applied methodology had a quantitative approach, non-experimental design, and correlational level, in which information was collected from 142 patients based on their medical records using a registration form. The results revealed the detection of 15 bacterial species, with most cases corresponding to Escherichia coli infections, accounting for 58.62% of cases. Of the total, 66.90% of isolates showed sensitivity to antibiotics, 3.03% had intermediate resistance, and 30.07% exhibited total resistance. Among these, 100.00% of isolates were sensitive to glycopeptides, while aminoglycosides and cephalosporins showed sensitivity rates of 76.49% and 74.66%, respectively. Fisher's exact test revealed a significance level greater than 0.05 when correlating bacterial resistance with the patients' clinical variables. Therefore, it is concluded that bacterial resistance is not related to glycemic control, the presence of comorbidities, or prior antibiotic treatments.
This item is licensed under a Creative Commons License